AstraZeneca
AZN
$63.67
Share price
0.82%
Change (1 day)
7.90%
Change (1 year)
Categories
Earnings for AstraZeneca (AZN)
Earnings in 2022 (TTM): $2.38 B
According to AstraZeneca's latest financial reports the company's current earnings (TTM) are $2.38 B. In 2021 the company made an earning of $1.01 B a decrease over its 2020 earnings that were of $5.18 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for AstraZeneca from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $2.38 B | 135.81% |
| 2021 | $1.01 B | -80.51% |
| 2020 | $5.18 B | 75.86% |
| 2019 | $2.95 B | -12.18% |
| 2018 | $3.35 B | -6.54% |
| 2017 | $3.59 B | -26.94% |
| 2016 | $4.91 B | 19.74% |
| 2015 | $4.10 B | 86.05% |
| 2014 | $2.20 B | -41.35% |
| 2013 | $3.76 B | -56.48% |
| 2012 | $8.65 B | -35.18% |
| 2011 | $13.34 B | 11.18% |
| 2010 | $12.00 B | |
| 2009 | $12.00 B | 31.29% |
| 2008 | $9.14 B | 12.97% |
| 2007 | $8.09 B | -1.48% |
| 2006 | $8.21 B | 26.36% |
| 2005 | $6.50 B | -2526.12% |
| 2004 | -$0.27 B | -106.52% |
| 2003 | $4.11 B | 2.94% |
| 2002 | $3.99 B | -32.95% |
| 2001 | $5.95 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.51 B | 844.59% | 🇺🇸 USA |
 Novartis NVS | $23.58 B | 889.14% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.92 B | 1,364.89% | 🇺🇸 USA |
 Abbott Laboratories ABT | $9.31 B | 290.65% | 🇺🇸 USA |
 Eli Lilly LLY | $6.54 B | 174.74% | 🇺🇸 USA |
 Sanofi SNY | $8.65 B | 262.97% | 🇫🇷 France |
 Biogen BIIB | $3.39 B | 42.32% | 🇺🇸 USA |
 Merck MRK | $17.77 B | 645.64% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $7.71 B | 223.49% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.58 B | 176.17% | 🇬🇧 UK |